Advances in ex vivo mRNA-based gene transfer for cell-based cancer immunotherapy
Florian Van Oers, Zoi Katana, Donovan Flumens, Eva Lion, Diana Campillo-Davo · 2026
Read Advances in ex vivo mRNA-based gene transfer for cell-based cancer immunotherapy by Florian Van Oers, Zoi Katana, Donovan Flumens, Eva Lion, Diana Campillo-Davo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13355714.txt.
Description
Florian Van Oers and co-authors review in 2026 a method that loads messenger RNA into immune cells outside the body to fight cancer. A brief electric pulse opens tiny pores in the cells, letting RNA in to make chosen proteins for a short time. The method has been used in dendritic cells, B cells, T cells, and natural killer cells.
Unlike virus-based methods, the RNA does not merge into the cell's DNA, which many see as safer and more flexible. The trade-off is that protein output fades fast. The authors weigh how well the method works across tumor types and set out its strengths and limits for designing cell therapies.
Catalog record
| CREATOR | Florian Van Oers, Zoi Katana, Donovan Flumens, Eva Lion, Diana Campillo-Davo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 96013 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |